HARRY ADHIKARI: Open Payments
NPI 1700582939 · STEELTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,464 in 131 payments from 27 companies in 2025. Trend: 2023 $1,957 · 2024 $3,074 · 2025 $2,464
Food & beverage: $2,464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $446 |
| Novo Nordisk Inc | 20 | $275 |
| Lilly USA, LLC | 11 | $206 |
| Exact Sciences Corporation | 8 | $194 |
| AstraZeneca Pharmaceuticals LP | 7 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $160 |
| Dexcom, Inc. | 6 | $114 |
| GlaxoSmithKline, LLC. | 5 | $114 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
Products named: JARDIANCE, VRAYLAR, MOUNJARO, QULIPTA, UBRELVY, Wegovy, Dexcom G6 Transmitter, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
